Noradrenergic sympathetic sprouting and cholinergic reinnervation maintains non-amyloidogenic processing of AβPP

Journal of Alzheimer's Disease

Volumn 38, Issue 4, 2014, Pages 867-879

  Nelson, Amy R ^a   Kolasa, Krystyna ^a   McMahon, Lori L ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

Alzheimer's disease; Amyloid ; Amyloid protein precursor; Cholinergic fibers; Muscarinic receptor M1; Nerve growth factor

Indexed keywords

AMYLOID PRECURSOR PROTEIN; MUSCARINIC M1 RECEPTOR; NERVE GROWTH FACTOR;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHOLINERGIC NERVE; CHOLINERGIC NERVE CELL; CHOLINERGIC REINNERVATION; COGNITION; CONTROLLED STUDY; GANGLIONECTOMY; HIPPOCAMPUS; IMMUNOHISTOCHEMISTRY; LONG TERM DEPRESSION; MALE; NERVE SPROUTING; NONHUMAN; NORADRENERGIC SYMPATHETIC SPROUTING; PRIORITY JOURNAL; PROTEIN PROCESSING; RAT; REINNERVATION; SYMPATHETIC NERVE; SYNAPSE;

ALZHEIMER'S DISEASE; AMYLOID-Β; AMYLOID-Β PROTEIN PRECURSOR; CHOLINERGIC FIBERS; MUSCARINIC RECEPTOR M1; NERVE GROWTH FACTOR;

ADRENERGIC FIBERS; AMYLOID BETA-PEPTIDES; AMYLOID BETA-PROTEIN PRECURSOR; AMYLOIDOSIS; ANIMALS; CHOLINERGIC FIBERS; HIPPOCAMPUS; MALE; NERVE GROWTH FACTOR; PEPTIDE FRAGMENTS; RATS; RATS, SPRAGUE-DAWLEY;

EID: 84890476714     PISSN: 13872877     EISSN: 18758908     Source Type: Journal    
DOI: 10.3233/JAD-130608     Document Type: Article

References (57)

1. Selkoe DJ (2011) Alzheimer's disease. Cold Spring Harb Perspect Biol 3, pii: a004457.
2. Anand P, SinghB(2013)Areviewon cholinesterase inhibitors for Alzheimer's disease. Arch Pharm Res 36, 375-399.
3. FisherA(2012) Cholinergic modulation of amyloid precursor protein processing with emphasis on M1 muscarinic recep tor: Perspectives and challenges in treatment of Alzheimer's disease. J Neurochem 120(Suppl 1), 22-33.
4. Levey AI, Edmunds SM, Koliatsos V, Wiley RG, Heilman CJ (1995) Expression of m1-m4 muscarinic acetylcholine receptor proteins in rat hippocampus and regulation by cholinergic innervation. J Neurosci 15, 4077-4092.
5. Jiang S, Wang Y, Ma Q, Zhou A, Zhang X, ZhangYW(2012) M1 muscarinic acetylcholine receptor interacts with BACE1 and regulates its proteosomal degradation. Neurosci Lett 515, 125-130.
6. Nitsch RM, Slack BE, Wurtman RJ, Growdon JH (1992) Release of Alzheimer amyloid precursor derivatives stimulated by activation of muscarinic acetylcholine receptors. Science 258, 304-307.
7. Perez SE, He B, Muhammad N, Oh KJ, Fahnestock M, Ikonomovic MD, Mufson EJ (2011) Cholinotrophic basal forebrain system alterations in 3xTg-AD transgenic mice. Neurobiol Dis 41, 338-352.
8. Medeiros R, Kitazawa M, Caccamo A, Baglietto-Vargas D, Estrada-Hernandez T, Cribbs DH, Fisher A, LaFerla FM (2011) Loss of muscarinic M1 receptor exacerbates Alzheimer's disease-like pathology and cognitive decline. Am J Pathol 179, 980-991.
9. Kolasa K, Harrell LE, Parsons DS (1997) Effect of hippocampal sympathetic ingrowth and cholinergic denervation on hippocampal phospholipase C activity and G-protein function. Neuroscience 77, 111-120.
10. Harrell LE, Kolasa K, Parsons DS, Ayyagari V (1995) Hippocampal sympathetic ingrowth and cholinergic denervation uniquely alter muscarinic receptor subtypes in the hippocampus. Brain Res 676, 386-393.
11. Harrell LE, Parsons D, Kolasa K (2001) Hippocampal sympathetic ingrowth occurs following 192-IgG-Saporin administration. Brain Res 911, 158-162.
12. Kolasa K, Parsons DS, Harrell LE (2000) Effect of phospholipaseCand protein kinaseCfollowing cholinergic denervation and hippocampal sympathetic ingrowth in rat hippocampus. Neuroscience 99, 25-31.
13. Kawaja MD, Crutcher KA (1997) Sympathetic axons invade the brains of mice overexpressing nerve growth factor. J Comp Neurol 383, 60-72.
14. Springer JE, Loy R (1985) Intrahippocampal injections of antiserum to nerve growth factor inhibit sympathohippocampal sprouting. Brain Res Bull 15, 629-634.
15. Loy R, Koziell DA, Lindsey JD, Moore RY (1980) Noradrenergic innervation of the adult rat hippocampal formation. J Comp Neurol 189, 699-710.
16. Crutcher KA, Brothers L, Davis JN (1981) Sympathetic noradrenergic sprouting in response to central cholinergic denervation; a histochemical study of neuronal sprouting in the rat hippocampal formation. Brain Res 210, 115-128.
17. Yu C, Crutcher KA (1995) Nerve growth factor immunoreactivity and sympathetic sprouting in the rat hippocampal formation. Brain Res 672, 55-67.
18. Stenevi F, Björklund A (1978) Growth of vascular sympathetic axons into the hippocampus after lesions of the septo-hippocampal pathway: A pitfall in brain lesion studies. Neurosci Lett 7, 219-224.
19. Crutcher KA, Madison R, Davis JN (1981) A study of the rat septohippocampal pathway using anterograde transport of horseradish peroxidase. Neuroscience 6, 1961-1973.
20. Scheiderer CL, McCutchen E, Thacker EE, Kolasa K, Ward MK, Parsons D, Harrell LE, Dobrunz LE, McMahon LL (2006) Sympathetic sprouting drives hippocampal cholinergic reinnervation that prevents loss of a muscarinic receptordependent long-term depression at CA3-CA1 synapses. J Neurosci 26, 3745-3756.
21. Booze RM, Mactutus CF, Gutman CR, Davis JN (1993) Frequency analysis of catecholamine axonal morphology in human brain. II. Alzheimer's disease and hippocampal sympathetic ingrowth. J Neurol Sci 119, 110-118.
22. Masliah E, Alford M, Adame A, Rockenstein E, Galasko D, Salmon D, Hansen LA, Thal LJ (2003) Abeta1-42 promotes cholinergic sprouting in patients with AD and Lewy body variant of AD. Neurology 61, 206-211.
23. Hashimoto M, Masliah E (2003) Cycles of aberrant synaptic sprouting and neurodegeneration in Alzheimer's and dementia with Lewy bodies. Neurochem Res 28, 1743-1756.
24. Colom LV, Castaneda MT, Hernandez S, Perry G, Jaime S, Touhami A (2011) Intrahippocampal amyloid-beta (1-40) injections injure medial septal neurons in rats. Curr Alzheimer Res 8, 832-840.
25. Roher AE, Ball MJ, Bhave SV, Wakade AR (1991) Betaamyloid from Alzheimer disease brains inhibits sprouting and survival of sympathetic neurons. Biochem Biophys Res Commun 174, 572-579.
26. Roberson MR, Kolasa K, Parsons DS, Harrell LE (1997) Cholinergic denervation and sympathetic ingrowth result in persistent changes in hippocampal muscarinic receptors. Neuroscience 80, 413-418.
27. Ayyagari V, Harrell LE, Parsons DS, Kolasa K (1995) The effect of cholinergic denervation and hippocampal sympathetic ingrowth on the internalization of muscarinic receptors in rat hippocampus. Brain Res 676, 394-397.
28. McCoy PA, McMahon LL (2010) Sympathetic sprouting in visual cortex stimulated by cholinergic denervation rescues expression of two forms of long-term depression at layer 2/3 synapses. Neuroscience 168, 591-604.
29. Pizzo DP, Thal LJ (2004) Intraparenchymal nerve growth factor improves behavioral deficits while minimizing the adverse effects of intracerebroventricular delivery. Neuroscience 124, 743-755.
30. Caccamo A, Oddo S, Billings LM, Green KN, Martinez-Coria H, Fisher A, LaFerla FM (2006) M1 receptors play a central role in modulating AD-like pathology in transgenic mice. Neuron 49, 671-682.
31. Barrett GL, Greferath U, Barker PA, Trieu J, Bennie A (2005) Co-expression of the P75 neurotrophin receptor and neurotrophin receptor-interacting melanoma antigen homolog in the mature rat brain. Neuroscience 133, 381-392.
32. Tuszynski MH (2007) Nerve growth factor gene therapy in Alzheimer disease. Alzheimer Dis Assoc Disord 21, 179-189.
33. Tuszynski MH (2007) Nerve growth factor gene delivery: Animal models to clinical trials. Dev Neurobiol 67, 1204-1215.
34. Eriksdotter-Jonhagen M, Nordberg A, Amberla K, Backman L, Ebendal T, Meyerson B, Olson L, Seiger, Shigeta M, Theodorsson E, Viitanen M, Winblad B, Wahlund LO (1998) Intracerebroventricular infusion of nerve growth factor in three patients with Alzheimer's disease. Dement Geriatr Cogn Disord 9, 246-257.
35. Eriksdotter-Jonhagen M, Linderoth B, Lind G, Aladellie L, Almkvist O, And reasen N, Blennow K, Bogdanovic N, Jelic V, Kadir A, Nordberg A, Sundstrom E, Wahlund LO, Wall A, Wiberg M, Winblad B, Seiger A, Almqvist P, Wahlberg L (2012) Encapsulated cell biodelivery of nerve growth factor to the basal forebrain in patients with Alzheimer's disease. Dement Geriatr Cogn Disord 33, 18-28.
36. Hao J, Ebendal T, Xu X, Wiesenfeld-Hallin Z, Eriksdotter-Jonhagen M (2000) Intracerebroventricular infusion of nerve growth factor induces pain-like response in rats. Neurosci Lett 286, 208-212.
37. Wahlberg LU, Lind G, Almqvist PM, Kusk P, Tornoe J, Juliusson B, Soderman M, Sellden E, Seiger A, Eriksdotter- Jonhagen M, Linderoth B (2012) Targeted delivery of nerve growth factor via encapsulated cell biodelivery in Alzheimer disease: A technology platform for restorative neurosurgery. J Neurosurg 117, 340-347.
38. Liu RM, van Groen T, Katre A, Cao D, Kadisha I, Ballinger C, Wang L, Carroll SL, Li L (2011) Knockout of plasminogen activator inhibitor 1 gene reduces amyloid beta peptide burden in a mouse model of Alzheimer's disease. Neurobiol Aging 32, 1079-1089.
39. Janickova H, Rudajev V, Zimcik P, Jakubik J, Tanila H, El-Fakahany EE, Dolezal V (2013) Uncoupling of M1 muscarinic receptor/G-protein interaction by amyloid beta(1-42). Neuropharmacology 67, 272-283.
40. Beach TG, Walker DG, Potter PE, Sue LI, Fisher A (2001) Reduction of cerebrospinal fluid amyloid beta after systemic administration of M1 muscarinic agonists. Brain Res 905, 220-223.
41. Wess J, Eglen RM, Gautam D (2007) Muscarinic acetylcholine receptors: Mutant mice provide new insights for drug development. Nat Rev Drug Discov 6, 721-733.
42. Sadot E, Gurwitz D, Barg J, Behar L, Ginzburg I, Fisher A (1996) Activation of m1 muscarinic acetylcholine receptor regulates tau phosphorylation in transfected PC12 cells. J Neurochem 66, 877-880.
43. Caccamo A, Fisher A, LaFerla FM (2009) M1 agonists as a potential disease-modifying therapy for Alzheimer's disease. Curr Alzheimer Res 6, 112-117.
44. Jones CK, Brady AE, Davis AA, Xiang Z, Bubser M, Tantawy MN, Kane AS, Bridges TM, Kennedy JP, Bradley SR, Peterson TE, Ansari MS, Baldwin RM, Kessler RM, Deutch AY, Lah JJ, Levey AI, Lindsley CW, Conn PJ (2008) Novel selective allosteric activator of the M1 muscarinic acetylcholine receptor regulates amyloid processing and produces antipsychotic-like activity in rats. J Neurosci 28, 10422-10433.
45. Haring R, Fisher A, Marciano D, Pittel Z, Kloog Y, Zuckerman A, Eshhar N, Heldman E (1998) Mitogen-activated protein kinase-dependent and protein kinase C-dependent pathways link the m1 muscarinic receptor to beta-amyloid precursor protein secretion. J Neurochem 71, 2094-2103.
46. TsangSW, Pomakian J, Marshall GA, VintersHV, Cummings JL, Chen CP, Wong PT, Lai MK (2007) Disrupted muscarinic M1 receptor signaling correlates with loss of protein kinase C activity and glutamatergic deficit in Alzheimer's disease. Neurobiol Aging 28, 1381-1387.
47. Hochstrasser T, Hohsfield LA, Sperner-Unterweger B, Humpel C (2013) beta-Amyloid induced effects on cholinergic, serotonergic, and dopaminergic neurons is differentially counteracted by anti-inflammatory drugs. J Neurosci Res 91, 83-94.
48. Knowles JK, Rajadas J, Nguyen TV, Yang T, LeMieux MC, Vander Griend L, Ishikawa C, Massa SM, Wyss-Coray T, Longo FM (2009) The p75 neurotrophin receptor promotes amyloid-beta(1-42)-induced neuritic dystrophy in vitro and in vivo. J Neurosci 29, 10627-10637.
49. Ovsepian SV, Herms J (2013) Drain of the brain: Low-affinity p75 neurotrophin receptor affords a molecular sink for clearance of cortical amyloid beta by the cholinergic modulator system. Neurobiol Aging 34, 2517-2524.
50. Ovsepian SV, Antyborzec I, O'Leary VB, Zaborszky L, Herms J, Oliver Dolly J (2013) Neurotrophin receptor p75 mediates the uptake of the amyloid beta (Abeta) peptide, guiding it to lysosomes for degradation in basal forebrain cholinergic neurons. Brain Struct Funct, doi: 10.1007/s00429-013-0583-x
51. Tolar M, Scott SA, Crutcher KA (1998) Sympathetic neurite outgrowth is greater on plaque-poor vs. plaque-rich regions of Alzheimer's disease cryostat sections. Brain Res 787, 49-58.
52. Tuszynski MH, Thal L, Pay M, Salmon DP, U HS, Bakay R, Patel P, Blesch A, Vahlsing HL, Ho G, Tong G, Potkin SG, Fallon J, Hansen L, Mufson EJ, Kordower JH, Gall C, Conner J (2005) A phase 1 clinical trial of nerve growth factor gene therapy for Alzheimer disease. Nat Med 11, 551-555.
53. Ayyagari PV, Harrell LE, Parsons DS, Kolasa K (1996) Sympathetic sprouting reverses decreases in membrane-associated activity of protein kinase C following septohippocampal denervation of the rat hippocampus. Brain Res 708, 205-208.
54. Harrell LE, Parsons DS, Kolasa K (2005) Pro- and anti-apoptotic evidence for cholinergic denervation and hippocampal sympathetic ingrowth in rat dorsal hippocampus. Exp Neurol 194, 182-190.
55. Harrell LE, Parsons DS, KolasaK(2005) The effect of central cholinergic and noradrenergic denervation on hippocampal sympathetic ingrowth and apoptosis-like reactivity in the rat. Brain Res 1033, 68-77.
56. Kolasa K, Harrell LE (2000) Apoptotic protein expression and activation of caspases is changed following cholinergic denervation and hippocampal sympathetic ingrowth in rat hippocampus. Neuroscience 101, 541-546.
57. Crutcher KA (1981) Cholinergic denervation of rat neocortex results in sympathetic innervation. Exp Neurol 74, 324-329.